Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT07604766 |
| Consolidated Lead Sponsor | Genmab |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase III |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 82 participants (ESTIMATED) |
| Registered Start Date | 2026-06-26 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| The First Hospital of Jilin University | Changchun, China | Open Hospital Dossier -> |
| Hunan Cancer Hospital | Changsha, China | Open Hospital Dossier -> |
| Sun Yat-sen Memorial Hospital | Guangzhou, China | Open Hospital Dossier -> |
| Sun Yat-sen University Cancer Center | Guangzhou, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.